Format

Send to

Choose Destination
Clin Cancer Res. 2018 Dec 4. pii: clincanres.3513.2018. doi: 10.1158/1078-0432.CCR-18-3513. [Epub ahead of print]

The Molecular Profiling Lottery: More Accuracy, Less Precision, and No Cost.

Author information

1
Department of Medicine, Committee on Clinical Pharmacology and Pharmacogenomics, Cancer Research Center, University of Chicago mratain@medicine.bsd.uchicago.edu.

Abstract

The concept of complete molecular profiling to select investigational treatment options is appealing; theoretically allowing the matching of patients to investigational drugs specifically targeted to molecular features of each patient's cancer. While some patients do benefit from such a strategy, the vast majority do not.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center